drugset / Trial / NCT04391842

Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis

NCT04391842

Phase 1 Completed 34 enrolled ZetrOZ, Inc.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to measure the effectiveness of Sustained Acoustic Medicine (SAM) treatment combined with diclofenac ultrasound coupling gel in patients with stage II and stage III knee osteoarthritis. The ability of the device to reduce pain, increase mobility, increase function of the affected leg, and improve quality of life in patients with knee osteoarthritis will be evaluated.

Timeline

Start
2019-09-01
Primary completion
2019-12-31
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical
Subject Diclofenac Other / unclassified 6 g Topical

Indications